Aurdan Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$269K Buy
1,028
+152
+17% +$39K 0.06% 99
2026
Q2
$220K Buy
+876
New +$188K 0.06% 95
2026
Q1
– Sell
-876
Closed -$200K – 89
2025
Q4
$200K Hold
876
– – 0.06% 86
2025
Q3
$203K Buy
+876
New +$178K 0.06% 90

Other funds holding ABBV

Aurdan Capital Management's ABBV Position: Q3 2026 in Review

Aurdan Capital Management increased its AbbVie (ABBV) stake by 17% in Q3 2026, buying an estimated $39K and bringing the position to 1,028 shares worth $269K. The position accounts for 0.06% of the portfolio, ranked #99.

Aurdan Capital Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,261 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Aurdan Capital Management held 1,028 shares of AbbVie worth $269K as of Q3 2026.
  • Aurdan Capital Management bought 152 AbbVie shares in Q3 2026, an estimated $39K.
  • AbbVie made up 0.06% of Aurdan Capital Management's portfolio in Q3 2026, its #99 holding.
  • Aurdan Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,261 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Aurdan Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.